GRACE Sindrome de dolor complejo regional.pptx

lisbethticonaandrade 25 views 71 slides Jun 18, 2024
Slide 1
Slide 1 of 71
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49
Slide 50
50
Slide 51
51
Slide 52
52
Slide 53
53
Slide 54
54
Slide 55
55
Slide 56
56
Slide 57
57
Slide 58
58
Slide 59
59
Slide 60
60
Slide 61
61
Slide 62
62
Slide 63
63
Slide 64
64
Slide 65
65
Slide 66
66
Slide 67
67
Slide 68
68
Slide 69
69
Slide 70
70
Slide 71
71

About This Presentation

sindrome de dolor complejo regiones, causalgia


Slide Content

Sindrome de Dolor Complejo Regional TRAUMATOLOGIA Y ORTOPEDIA DOCENTE: DR. FRANCISCO OTALORA MR. GRACE TICONA ANDRADE

01 Historia sobre terminologia OBJETIVOS Conocer 02 Definir Definicion 03 Conocer que situaciones implican Etiologia 04 D escribir las bases Fisiopatologia 05 Diagnostico 06 Tratamiento

TERMINOLOGIA CONDICIÓN DOLOROSA: MÚLTIPLES NOMBRES DESDE SU APARCIÓN CAUSALGIA SÍNDROME DE H O MB R O - M ANO DISTROFIA SI M P Á T I C O R E F L E J A 1º TÉRMINO EN APARECER D I S T R O FIA R E F L E J A NEUROVASCULAR

Dolor regional (MMSS MMII fundamentalmente) Continúo NO distribución nerviosa o metamérica Normalmente traumatológica DESPROPORCIONADO al evento que lo causó Manifestaciones vegetativas Edema Cambios tróficos Cambios de temperatura y color Alteraciones sudoración. Curso variable en el tiempo Mejor pronóstico cuando se trata inicialmente DEFINICION

Incidencia: 7% de pacientes tras trauma, incision o cirugia Pico incidencia: 35 a 60 años (90% tras traumatismo, 10% espontaneo ) Predominio en mujeres: 4:1 Extremidades superiores: mas frecuente Unilateral Niños y ancianos Duracion media: 15 años Cronificacion >12 meses 15% Dolor incontrolable: 15% EPIDEMIOLOGIA

ETIOLOGIA

F . de s e n c a de n a n t e s F . P r ed i s p o n e n t e s Genéticos M e t a b ó li c os Psicológicos Inmovilizaciones Trauma Cirugía Rehabilitación mal realizada Fármacos (yodo, TBC) Ninguno… CRONIFICACIÓN

FISIOPATOLOGIA 1. Respuesta inflamatoria 2. Sensibilizacion central y periferica

CRITERIOS DE BUDAPEST D I A G NÓ S T I C O 1. PURAMENTE CLÍNICO S I G N OS S Í N T O M AS 2. DIAGNÓSTICO DE EXCLUSIÓN 3. EXPLORACIONES COMPLEMENTARIAS ( Confirman y apoyan diagnóstico ) 4. NO PRECISA DE ESTUDIOS DE LABORATORIO

V . DI A G N Ó S TI C O Radiología simple Gammagrafía ósea con Tc99 . RNM Termografía . Estudios en el sist. nervioso autónomo/ EMG Estudios electrodiagnósticos . Determinacion Bioquímica

GA MM A GRA F Í A ÓSEA HIPERVASCULARIZACIÓN ÓSEA HIPERCAPTACIÓN ÓSEA TEST DE F E N T OL A M I NA DISMINUCIÓN DEL DOLOR Y LA HIPERALGESIA SUPERIOR AL 50% DURANTE CASI 12 HORAS R AD I O G R A F Í A SIMPLE IMÁGENES INCIPIENTES DE OSTEOPOROSIS MOTEADA REABSORCIÓN ÓSEA SUBPERIÓSTICA T E RMO G R A F Í A DIFERENCIA EN LA MEDICIÓN DE TEMPERATURA ENTRE LA EXTREMIDAD AFECTADA Y LA SANA

. D i s f unc i ó n Motora Debilidad Amplitud de movimiento reducida Temblor Distonía Mioclonus Disminución de la fuerza muscular, s/t la fuerza de prensió n Distrofia > o < crecimiento de uñas y cabello Ca m bi o s e n pi el : pal i de z, f ib r o s i s, hiperqueratosis, piel brillante y fina

Sensoriales Dolo r in t en s o . Hiperestesia Hiperalgesia Alodinia Deficiencias sensoriales como trastorno hemisensorial Hipoestesia trigeminal Autónomos Tumefacción Cambios de color y temperatura Anomalías de sudoración

Objetivo : Mejorar la función: evitar secuelas óseas y articulares Aliviar el dolor y la rigidez Conseguir remisión de síntomas  restauración funcional Tratamiento multidisciplinar  3 elementos clave: Tratamiento del dolor. Rehabilitación. Terapia psicológica . Fundamental : C o n s e nso g e n e r al i z a d o : lo s pa c i e n t e s qu e n o r e s po n d e n a un nivel de tratamiento aceptable tras 12–16 semanas Medidas intervencionistas TRATAMIENT0

. BIFOSFONATOS / CALCITONINA OPIOIDES / AINES KETAMINA SUBANESTÉSICA IV AN T I D E P R E SI V O S / AN T I C O NVU L SI V O S ANESTÉSICOS TÓPICOS BLOQUEO DE NERVIO SIMPÁTICO BLOQUEO REGIONAL IV BLOQUEO DE NERVIO SOMÁTICO BLOQUEO DE CATÉTER EPIDURAL Y DE PLEXO NEUROESTIMULACIÓN VÍA INTRATECAL ( BACLOFENO ) SIMPATECTOMÍA ESTIMULACIÓN CORTEZA MOTRIZ TRATAMIENTOS NO INVASIVOS TRATAMIENTOS INVASIVOS

. DOLOR NEUROPÁTICO + Analgésicos periféricos no opioides + Opioides débiles + Analgésicos periféricos NO opioides + Analgésicos opioides potentes + Analgésicos periféricos NO opioides

AMITRIPTILINA VENLAFAXINA 10-75 mg/día 7 5 -150m g / d ía ANTIDEPRESIVOS OXCARBACEPINA GABAPENTINA TOPIRAMATO PREGABALINA 600-2400 mg/día 900-3200 mg/día 150-400 mg/día 150-600 mg/día ( 3 tomas ) ( 3 tomas ) ( 2 tomas ) ( 2 tomas ) ANTICONVULSIVOS TR A T A M I E N T OS TÓPICOS C AP S A IC INA 4-5 apli/día LIDOCAINA 1. TRATAMIENTO NO INVASIVO

DOSIS ALTERNAS ( 60-80 mg/día) 2 semanas. CORTICOESTEROIDES EFCTIVIDAD A CORTO PLAZO ( < 6 meses ) PRAZOSINA/TERAZOSINA MAL TOLERADOS ( HIPTENSIÓN ORTOSTÁTICA Y DEPRESIÓN ) S I M P A T I C O L Í T I C O S INGERIBLES CLONIDINA TRANSDÉRMICA/GEL DISMINUCIÓN DE ALODINIA DONDE SE APLICA

Únicos fármacos que aportan al tratamiento del SDRC. B I F OS F O N A T OS 1º Linea para control del dolor en fase aguda Inbidores de la reabsorción ósea CALCITONINA Elección en estadios avanzados (corto plazo) OPIOIDES NO EFICACIA PROBADA

NO ESTA CLARA SU EFICACIA BLOQUEADORES CANALES CALCIO ÚTIL EN PACIENTES RESISTENTES AL TRATAMIENTO GRAN CANTIDAD DE EFECTOS ADVERSOS ANTAGONISTAS NMDA (KETAMINA ) V I T A MINA C PREVENTIVO ( FRACTURAS DE COLLES )

2. TRATAMIENTO INVASIVO Bloqueo simpatico

Bloqueo Nerviosos

Estimulación medular La evidencia para la estimulación medular es fuerte a corto plazo y moderada a largo plazo (B-C).

La administración de medicación por vía intratecal ha demostrado su efectividad en los pacientes con SDRC que no responden a la EME, con distonía asociada al SDRC Infusión espinal de fármaco

CONCLUSIONES E x t re m ar l o s cu i da d os dura n te l a c i rug í a, l i m i ta nd o el t i e m p o quirúrgico y de la isquemia. Buen control del dolor postoperatorio Su diagnóstico en puramente clínico li m i t a l a ac titud Tratamiento precoz y multidisciplinar E l n o - c o n o c i m i e nt o d e l a f i s i o p a t o l o g ía terapéutica 5. Es una enfermedad real y claramente invalidante

BIBLIOGRAFÍA

Identifying information It’s the closest planet to the Sun and the smallest in the Solar System Mercury Venus has a beautiful name and is the second planet from the Sun Venus Despite being red, Mars is actually a cold place. It’s full of iron oxide dust Mars

About the patient Age: 70 Gender: Male Allergies: None Observations Earth is the third planet from the Sun and the only one that harbors life in the Solar System. This is where we all live Mercury Mercury is the closest planet to the Sun 2005 Mars Despite being red, Mars is a cold place 2010 Venus Venus is the second planet from the Sun 2015

A picture is worth a thousand words

Physical examination Mercury Mercury is the closest planet to the Sun Venus Venus is the second planet from the Sun Mars Mars is actually a very cold place Jupiter Jupiter is the biggest planet of them all Saturn It’s composed of hydrogen and helium Neptune It’s the farthest planet from the Sun

Mercury is the closest planet to the Sun and the smallest one in the Solar System. This planet's name has nothing to do with the liquid metal, since Mercury was named after the Roman messenger god Discussion summary

Findings Follow the link in the graph to modify its data and then paste the new one here. For more info, click here Evolution Jupiter Jupiter is the biggest planet of them all Neptune It’s the farthest planet from the Sun Saturn It’s a gas giant and has several rings 125,000 Big number

Awesome words

Prevalence Mercury It’s the closest planet to the Sun 70% Mars Mars is actually a very cold place 30% 50,000,363 Total cases

Review of the system “Mercury is the closest planet to the Sun and the smallest of them all” Dr. Jenna Doe “Venus has a beautiful name and is the second planet from the Sun” Dr. Louis Smith “Despite being red, Mars is actually a cold place. It’s full of iron oxide dust” Dr. Lisa Jones “Neptune is the farthest planet from the Sun. It's also the fourth-largest” Dr. John Lewis

Mercury is the closest planet to the Sun Mercury Venus is the second planet from the Sun Venus Mars is actually a very cold place Mars Jupiter is the biggest planet of them all Jupiter It’s composed of hydrogen and helium Saturn It’s the farthest planet from the Sun Neptune Diagnosis

Treatment It’s the closest planet to the Sun and the smallest in the Solar System Mercury Venus has a beautiful name and is the second planet from the Sun Venus 2 1

Comparison Venus Mars Jupiter Venus is the second planet from the Sun Yes Yes No Saturn is composed of hydrogen and helium Yes No Yes Jupiter is the biggest planet of them all No No Yes

140,000 Big numbers catch your audience’s attention

Patient monitoring Week 1 Mercury is the closest planet to the Sun 10% Mercury 30% Venus 60% Mars Week 2 Despite being red, Mars is a cold place 70% Jupiter 10% Saturn 20% Neptune Week 3 Neptune is the farthest planet from the Sun 40% Saturn 30% Ceres 30% Earth

10% Mercury is the closest planet to the Sun Mercury Post-prevention 20% Despite being red, Mars is a cold place Mars 30% It’s the second planet from the Sun Venus 40% It’s the farthest planet from the Sun Neptune

Contraindications and indications You should You shouldn’t Describe the things patients should do here Describe the things patients should do here Describe the things patients should do here Describe the things patients should do here Describe the things patients shouldn't do here Describe the things patients shouldn't do here Describe the things patients shouldn't do here Describe the things patients shouldn't do here

Case timeline Day 1 Mercury is the closest planet to the Sun Day 2 Venus is the second planet from the Sun Day 3 Mars is actually a very cold place Day 4 Neptune is very far from the Sun

Conclusions Do you know what helps you make your point clear? Lists like this one: They’re simple You can organize your ideas clearly You’ll never forget to buy milk! And the most important thing: the audience won’t miss the point of your presentation ever again

References AUTHOR (YEAR). Title of the publication . Publisher AUTHOR (YEAR). Title of the publication . Publisher AUTHOR (YEAR). Title of the publication . Publisher AUTHOR (YEAR). Title of the publication . Publisher AUTHOR (YEAR). Title of the publication . Publisher AUTHOR (YEAR). Title of the publication . Publisher AUTHOR (YEAR). Title of the publication . Publisher

Our team You can speak a bit about this person here Peter Doe You can speak a bit about this person here Anna Johnson

You can replace the image on the screen with your own work. Just right-click on it and select “Replace image” Visit our website!

Do you have any questions? [email protected] +91 620 421 838 yourcompany.com Thanks! Please keep this slide for attribution

Medicaments icon pack

Here’s an assortment of alternative resources whose style fits the one of this template Orthopedics and traumatology horizontal banners Traumatology orthopedics 2x2 flat images Orthopedics color icons Alternative resources

Resources Did you like the resources on this template? Get them for free at our other websites: Vectors Orthopedics and traumatology horizontal banners Orthopedics design concept Photos Caregiver holding old man's shoulder Osteopathist treating a patient on his feet Side view doctor explaining a foot radiography Medium shot doctor talking to patient Medium shot doctor checking kid's mouth Icon Icon Pack: Medicaments

In order to use this template, you must credit Slidesgo by keeping the Thanks slide. You are allowed to: - Modify this template. - Use it for both personal and commercial projects. You are not allowed to: - Sublicense, sell or rent any of Slidesgo Content (or a modified version of Slidesgo Content). - Distribute Slidesgo Content unless it has been expressly authorized by Slidesgo. - Include Slidesgo Content in an online or offline database or file. - Offer Slidesgo templates (or modified versions of Slidesgo templates) for download. - Acquire the copyright of Slidesgo Content. For more information about editing slides, please read our FAQs or visit Slidesgo School: https://slidesgo.com/faqs and https://slidesgo.com/slidesgo-school Instructions for use

As a Premium user, you can use this template without attributing Slidesgo or keeping the "Thanks" slide. You are allowed to: Modify this template. Use it for both personal and commercial purposes. Hide or delete the “Thanks” slide and the mention to Slidesgo in the credits. Share this template in an editable format with people who are not part of your team. You are not allowed to: Sublicense, sell or rent this Slidesgo Template (or a modified version of this Slidesgo Template). Distribute this Slidesgo Template (or a modified version of this Slidesgo Template) or include it in a database or in any other product or service that offers downloadable images, icons or presentations that may be subject to distribution or resale. Use any of the elements that are part of this Slidesgo Template in an isolated and separated way from this Template. Register any of the elements that are part of this template as a trademark or logo, or register it as a work in an intellectual property registry or similar. For more information about editing slides, please read our FAQs or visit Slidesgo School: https://slidesgo.com/faqs and https://slidesgo.com/slidesgo-school Instructions for use (premium users)

This presentation has been made using the following fonts: Alata ( https://fonts.google.com/specimen/Alata ) Barlow ( https://fonts.google.com/specimen/Barlow ) #362c34 #ffffff #918377 #ffefd9 #ff9d6c Fonts & colors used

Create your Story with our illustrated concepts. Choose the style you like the most, edit its colors, pick the background and layers you want to show and bring them to life with the animator panel! It will boost your presentation. Check out How it works. Pana Amico Bro Rafiki Cuate Storyset

You can easily resize these resources without losing quality. To change the color , just ungroup the resource and click on the object you want to change. Then, click on the paint bucket and select the color you want. Group the resource again when you’re done. You can also look for more infographics on Slidesgo. Use our editable graphic resources...

JANUARY FEBRUARY MARCH APRIL MAY JUNE PHASE 1 PHASE 2 Task 1 Task 2 Task 1 Task 2 JANUARY FEBRUARY MARCH APRIL PHASE 1 Task 1 Task 2

You can resize these icons without losing quality. You can change the stroke and fill color ; just select the icon and click on the paint bucket/pen . In Google Slides, you can also use Flaticon’s extension , allowing you to customize and add even more icons. ...and our sets of editable icons

Educational Icons Medical Icons

Business Icons Teamwork Icons

Help & Support Icons Avatar Icons

Creative Process Icons Performing Arts Icons

Nature Icons

SEO & Marketing Icons
Tags